1394-Sinonasal Carcinoma Therapeutic Vulnerabilities

Researchers utilized single-nucleus RNA sequencing to analyze rare and aggressive sinonasal carcinomas, specifically focusing on subtypes with IDH2 and SMARCA4 mutations. The study successfully identified seventeen distinct cell types and four malignant clusters, revealing that these tumors are composed of diverse cellular states including neuroendocrine-like and stress-adaptive programs. Through detailed transcriptional profiling, the authors discovered that IDH2-mutated tumors frequently overexpress KIT, while SMARCA4-mutated cases show significant MET upregulation. Additionally, the data nominated the collagen-DDR1 signaling axis as a notable therapeutic vulnerability, suggesting that multi-target kinase inhibitors could be effective treatments. These findings establish a new precision oncology framework by connecting molecular classifications with specific, actionable drug targets. This comprehensive atlas provides a vital resource for developing targeted therapies for patients with these poorly understood malignancies.References:Zhdanovich Y, Geisenberger C, Mochmann L H, et al. Single nucleus RNA profiling reveals potential therapeutic vulnerabilities in sinonasal carcinomas[J]. NPJ Precision Oncology, 2026, 10(1): 260.前往小宇宙评论区与主播互动